期刊文献+

Guillain-Barre综合征患儿血清白介素-18、白介素-13水平的变化

Changes of levels in serum IL-18 and IL-13 in children with Guillain-Barre syndrome
下载PDF
导出
摘要 目的探讨白介素(IL)-18、IL-13在Guillain-Barre综合征(GBS)患儿血清中的含量变化及意义。方法采用酶联免疫吸附法(ELISA)测定GBS患儿急性期与恢复期血清IL-18、IL-13水平,并与正常对照组比较。结果GBS患儿急性期血清IL-18[(44.87±7.53)pg/ml]与IL-13[(37.46±6.94)pg/ml]水平均明显高于恢复期[和(38.25±5.86)pg/ml、(32.14±6.89)pg/ml]和正常对照组[(32.35±4.93)pg/ml、(24.76±5.59)pg/ml](均P<0.01);且病情重者[(47.02±8.39)pg/ml、(39.46±6.72)]pg/ml]明显高于病情轻者[(41.96±5.58)pg/ml、(34.51±6.25)pg/ml](均P<0.05);GBS患者恢复期血清IL-18、IL-13水平仍高于正常对照组(均P<0.01);相关分析发现GBS病情与血清IL-18、IL-13水平呈正相关(r=0.116,0.078,均P<0.05)。结论GBS患儿血清IL-18、IL-13含量增加,其可能参与了GBS的发病机制。 Objective To explore the changes and role of levels of serum IL-18 and IL-13 in children with Guillain-Barre syndrome (GBS). Methods The levels of serum IL-13 and IL-18 were determined by enzyme-linked immunoabsordent assay(ELISA) in 42 children with GBS (GBS group) in stages of acute and recovery ,and compared with the normal control (NC) group. Results The serum levels of IL-18 and IL-13 in GBS group at acute stage [ (44, 87 ± 7.53 ) pg/ml, ( 37.46 ± 6.94 ) pg/ml ] were significantly higher than those at recovery stage [ ( 38.25 ± 5.86 ) pg/ml, ( 32.14 ± 6.89 ) pg/ml ] and NC group [ (32.35± 4.93 ) pg/ml, ( 24.76 ± 5.59 ) pg/ml] ( all P 〈 0.01 ). The .serum levels of IL-18 and IL-13 in serious group [ ( 47.02 ± 8.39 ) pg/ml, ( 39.46 ± 6.72 ) pg/ml ] were significantly higher than those in the mild group [ ( 41.96 ± 5.58 ) pg/ml, ( 34.51 ± 6.25 ) pg/ml ] ( all P 〈 0. 05 ). The serum levels of IL-18 and IL-13 in GBS group at recover stage were significantly higer than those NE group (all P 〈 0. 01 ). There were positive correlations betwent the serum levels of IL-18, IL-13 and severity of GBS ( r = 0. 116,0. 078, all P 〈 0. 05 ). Conclusion The serum levels of IL-18 and IL-13 in children with GBS increase and they may play an important role in the pathogenesis.
出处 《临床神经病学杂志》 CAS 北大核心 2007年第6期456-457,共2页 Journal of Clinical Neurology
关键词 GUILLAIN-BARRE综合征 白介素-18 白介素-13 Guillain-Barre syndrome intreleukin-18 interleukin-13
  • 相关文献

参考文献7

  • 1何志义,吕昌龙,刘风芝,王钢,付国,李绍英.急性Guillain-Barre综合征患者血清sIL-2R和sIL-6R水平的测定[J].临床神经病学杂志,2000,13(2):102-103. 被引量:1
  • 2Losy J, Niezgoda A. IL-18 in patients with multiple sclerosis[J].Acta Neurol Scand, 2001,104:171.
  • 3Jander S, Stoll G. Increased serum levels of the interferongammainducing cytokine interleukin-18 in myasthenia gravis[J]. Neurology,2002,59:287.
  • 4Im SH, Barchan D, Maiti PK, et al. Suppression of experimental myasthenia gravis, a B cell-mediated autoimmune disease, by blockade of IL-18[J]. FASEB J, 2001,15:2140.
  • 5de Waal Malefyt R,Figdor CG,Huijkens R,et al. Effects of IL-13 on phenotype, cytokine production and cytotoxic function of human monocyte. Comparison with IL-4 and modulation by IFN-γ of IL-10[J].J Immunol,2000,158:6370.
  • 6文维群,胡章勇,章廉.IL-18与疾病相关性的实验研究进展[J].国外医学(预防.诊断.治疗用生物制品分册),2001,24(1):26-29. 被引量:7
  • 7高立芬,刘君炎.IL-18与免疫相关性疾病[J].国外医学(免疫学分册),2001,24(3):165-167. 被引量:9

二级参考文献18

  • 1Yoshimoto T et al. Proc Natl Acad Sci USA, 1999;96(24): 13962-13966
  • 2Rothe H et al. J Immunol, 1999; 163(3):1230-1236
  • 3Furlan R et al. J Immunol, 1999; 163(5):2403-2409
  • 4Hu HZ et al. Immunology, 1999; 98(3):379-385
  • 5Wild JS et al. J Immunol, 2000; 164(5):2701-2710
  • 6Seki S et al. Immunol Rev, 2000; 174:35-46
  • 7Barreios AP et al. Scand J Immunol, 2000; 51(5):472-478
  • 8Ohkusu K et al. Infect Immun, 2000; 68(5):2449-2456
  • 9Xing Z et al. J Immunnol,2000; 164(5):2575-2584
  • 10Tanaka-Kataoka M et al. Cytokine, 1999; 11 (8):593-599

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部